• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,201.65
  • 0.64 %
  • $52.38
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Telesis Bio, Inc. (TBIO) Stock Price, News & Analysis

Telesis Bio, Inc. (TBIO) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.90

-$0.05

(-5.26%)

Day's range
$0.9
Day's range
$0.9
50-day range
$0.889
Day's range
$5.17
  • Country: US
  • ISIN: US1920031010
52 wk range
$0.89
Day's range
$15.46


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -6.53
  • Piotroski Score 3.00
  • Grade Sector Weight
  • Symbol (TBIO)
  • Company Telesis Bio, Inc.
  • Price $0.90
  • Changes Percentage (-5.26%)
  • Change -$0.05
  • Day Low $0.90
  • Day High $0.90
  • Year High $15.46

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/07/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$28.29
  • Trailing P/E Ratio -0.13
  • Forward P/E Ratio -0.13
  • P/E Growth -0.13
  • Net Income $-47,724,000

Income Statement

Quarterly

Annual

Latest News of TBIO

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Telesis Bio, Inc. Frequently Asked Questions

  • What were the earnings of TBIO in the last quarter?

    In the last quarter Telesis Bio, Inc. earnings were on Thursday, November, 7th. The Telesis Bio, Inc. maker reported -$3.83 EPS for the quarter, beating analysts' consensus estimates of -$6.58 by $2.75.

  • What is the Telesis Bio, Inc. stock price today?

    Today's price of Telesis Bio, Inc. is $0.90 — it has decreased by -5.26% in the past 24 hours. Watch Telesis Bio, Inc. stock price performance more closely on the chart.

  • Does Telesis Bio, Inc. release reports?

    Yes, you can track Telesis Bio, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Telesis Bio, Inc. stock forecast?

    Watch the Telesis Bio, Inc. chart and read a more detailed Telesis Bio, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Telesis Bio, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Telesis Bio, Inc. stock ticker.

  • How to buy Telesis Bio, Inc. stocks?

    Like other stocks, TBIO shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Telesis Bio, Inc.'s EBITDA?

    Telesis Bio, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Telesis Bio, Inc.’s financial statements.

  • What is the Telesis Bio, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -1.7348504126, which equates to approximately -173.49%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Telesis Bio, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Telesis Bio, Inc.'s financials relevant news, and technical analysis. Telesis Bio, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Telesis Bio, Inc. stock currently indicates a “sell” signal. For more insights, review Telesis Bio, Inc.’s technical analysis.

  • A revenue figure for Telesis Bio, Inc. for its last quarter?

    Telesis Bio, Inc. published it's last quarterly revenues at $1.55 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.